Trademark Overview
On Monday, May 5, 2025, a trademark application was filed for BITLUMOZ with the United States Patent and Trademark Office. The USPTO has given the BITLUMOZ trademark a serial number of 99170243. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 5, 2025. This trademark is owned by Disc Medicine, Inc.. The BITLUMOZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity